Melatonin: Sleep Timing and Focus
Melatonin shifts your body clock and nudges sleep onset by minutes, not hours. The trials tested dose and timing, and both changed the result.

Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
How Does Melatonin Work in the Brain?
The pineal gland releases melatonin at night as a circadian time cue. In a study of 116 healthy adults, room light in the hours before bed delayed melatonin onset in 99% of them and shortened melatonin duration by about 90 minutes compared with dim light (room light melatonin study, PMID 21193540).
Taken at the right time, melatonin moves the body clock. In a phase response curve study of 34 adults, 0.5 mg gave its largest phase advance when taken in the afternoon, 2 to 4 hours before the evening rise in melatonin, and 0.5 mg and 3.0 mg produced similar-sized shifts when each was given at its best time (PMID 20410229).
Given at midday to 20 healthy men, doses from 0.1 to 10 mg raised sleepiness and cut sleep-onset latency, and the 0.1 and 0.3 mg doses produced blood levels within the normal nocturnal range. The same doses also lowered correct responses on an auditory vigilance task, so daytime melatonin is not a focus aid (daytime serum melatonin study, PMID 8127888).
Older adults tend to have lower nocturnal melatonin. In insomniacs over 50, a physiologic 0.3 mg dose restored sleep efficiency and brought blood levels back to normal, while 3.0 mg caused hypothermia and kept melatonin elevated into daylight hours (age-related insomnia trial, PMID 11600532).
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- Across 19 placebo-controlled trials, melatonin shortened sleep latency by 7.06 minutes, added 8.25 minutes of total sleep and improved sleep quality, and the effect did not fade with continued use (PMID 23691095).
- In delayed sleep-wake phase disorder, 0.5 mg taken 1 hour before the desired bedtime, plus a fixed bedtime, moved sleep onset 34 minutes earlier than placebo (PMID 29912983).
- Low doses can be enough. In older insomniacs, 0.3 mg restored sleep efficiency, while 3.0 mg left blood melatonin high into the daylight hours (PMID 11600532).
- For jet lag across 5 or more time zones, 9 of 10 trials found melatonin near the destination bedtime reduced jet lag, with a number needed to treat of 2 (PMID 12076414).
- Taken at bedtime, prolonged-release 2 mg did not impair psychomotor function, memory recall or driving at 1 hour, 4 hours or the next morning in adults 55 and older, unlike zolpidem (PMID 18763235).
- A sleep-disorder meta-analysis found the most convincing evidence for faster sleep onset in primary insomnia and delayed sleep phase syndrome, and for regulating sleep-wake patterns in blind patients (PMID 28648359).
- Across 37 RCTs, the most common adverse events were daytime sleepiness (1.66%), headache, dizziness and hypothermia, and most resolved within a few days or on stopping (PMID 31722088).
- Whether melatonin is safe over years. The 37-RCT safety review followed people for up to 29 weeks, most for 4 weeks or less (PMID 31722088).
- Whether it sharpens a healthy brain. In the healthy-subject trials of a 22-RCT neurocognitive meta-analysis, daytime melatonin lowered accuracy on correct responses, and pooled memory scores were not reduced (PMID 33957167).
- Whether it slows Alzheimer disease. In a meta-analysis, patients treated for more than 12 weeks scored 1.82 MMSE points higher than comparison groups, and mild-stage patients 1.89 points higher (PMID 33957167), and in a 6-month Alzheimer trial of prolonged-release 2 mg, MMSE and daily-living scores improved but mean ADAS-Cog did not differ (PMID 24971004).
- What your bottle actually contains. In 31 supplements, melatonin ran from 83% below to 478% above the label, and 8 contained serotonin (PMID 27855744).
- Whether results carry to people without a delayed clock. The night-owl trial only enrolled patients whose melatonin rhythm ran late (PMID 29912983).
- How it interacts with epilepsy and warfarin. The jet lag Cochrane review cites case reports of harm in both groups and calls for study (PMID 12076414).
Frequently Asked Questions
What dose of melatonin works best for sleep?
There is no single best dose; it depends on who is taking it and why. In insomniacs over 50, the physiologic 0.3 mg dose restored sleep efficiency and normal blood levels; 3.0 mg also helped sleep but caused hypothermia and kept melatonin elevated into daylight (age-related insomnia trial, PMID 11600532). For jet lag, 0.5 to 5 mg worked similarly, though people fell asleep faster and slept better on 5 mg than 0.5 mg, and doses above 5 mg were no more effective (PMID 12076414).
When should you take melatonin?
It depends on the goal. To fall asleep earlier with a late body clock, the delayed sleep phase trial used 0.5 mg 1 hour before the desired bedtime (PMID 29912983). To shift the clock itself, 0.5 mg worked best in the afternoon, 2 to 4 hours before your evening melatonin rise (phase response curve study, PMID 20410229).
Does melatonin affect focus or memory the next day?
Taken at bedtime, prolonged-release 2 mg did not impair psychomotor function, memory recall or driving skills the next morning in healthy adults 55 and older (psychomotor and driving study, PMID 18763235), and more insomnia patients aged 55-80 improved in both sleep quality and morning alertness than on placebo, 26% vs 15% (PMID 17875243). Taken during the day it is a different story: it lowered vigilance task accuracy (PMID 8127888).
Are melatonin gummies accurately labeled?
Often not. Of 25 US melatonin gummy brands tested, 22 (88%) were off their label, with measured melatonin from 74% to 347% of the stated amount; one held no detectable melatonin but 31.3 mg of CBD (Cohen, melatonin gummies study in JAMA 2023, PMID 37097362). An earlier study of 31 supplements found lot-to-lot swings of up to 465% (PMID 27855744). That matters more as use grows: reported melatonin use among US adults rose from 0.4% in 1999-2000 to 2.1% in 2017-2018 (melatonin supplement use trends, PMID 35103775).
Is melatonin safe for children in the house?
Store it like medicine. Pediatric melatonin ingestions reported to US poison centers rose 530% from 2012 to 2021; the rise in hospitalizations came mainly from unintentional ingestions in children 5 and under, five children needed mechanical ventilation and two died (pediatric melatonin ingestions report, PMID 35653284).
Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links support HighPeptides at no extra cost.
Related HighPeptides Research
Peer-Reviewed References
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →Educational purposes only. Not medical advice.
Melatonin is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it with epilepsy, warfarin or other sedating medicines, or for a child.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.